Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

CHIEF EXECUTIVE OFFICER

COO, CFO AND SECRETARY

HEAD OF R&D

GENERAL COUNSEL

HEAD OF RESEARCH AND DEVELOPME

Chief Executive Officer

Head of Research and Developme

COO, CFO and Secretary

General Counsel

Chief Medical Officer

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/progressive low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients ...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-05-03	Premium	sold	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2024-05-03	Premium	sold	Premium	Premium	Premium	COO, CFO AND SECRETARY
2024-05-02	Premium	sold	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2024-05-02	Premium	sold	Premium	Premium	Premium	COO, CFO AND SECRETARY
2024-05-01	Premium	sold	Premium	Premium	Premium	COO, CFO AND SECRETARY
2024-05-01	Premium	sold	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2024-04-18	Premium	sold	Premium	Premium	Premium	HEAD OF R&D
2024-03-25	Premium	sold	Premium	Premium	Premium	HEAD OF R&D
2024-03-11	Premium	sold	Premium	Premium	Premium	HEAD OF R&D
2024-02-27	Premium	sold	Premium	Premium	Premium	HEAD OF R&D
2024-02-16	Premium	sold	Premium	Premium	Premium	GENERAL COUNSEL
2024-02-16	Premium	sold	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2024-02-16	Premium	sold	Premium	Premium	Premium	COO, CFO AND SECRETARY
2024-02-16	Premium	sold	Premium	Premium	Premium	HEAD OF RESEARCH AND DEVELOPME
2024-02-15	Premium	acquired	Premium	Premium	Premium	COO, CFO AND SECRETARY
2024-02-15	Premium	acquired	Premium	Premium	Premium	HEAD OF RESEARCH AND DEVELOPME
2024-02-15	Premium	acquired	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2024-02-15	Premium	acquired	Premium	Premium	Premium	GENERAL COUNSEL
2023-11-16	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2023-11-16	Premium	sold	Premium	Premium	Premium	Head of Research and Developme
2023-11-16	Premium	sold	Premium	Premium	Premium	COO, CFO and Secretary
2023-11-16	Premium	sold	Premium	Premium	Premium	General Counsel
2023-11-15	Premium	acquired	Premium	Premium	Premium	COO, CFO and Secretary
2023-11-15	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2023-11-15	Premium	acquired	Premium	Premium	Premium	Head of Research and Developme

DAWN - Day One Biopharmaceuticals, Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for DAWN